Sklar LA - Search Results

1

Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.

Guo H, Yang J, Gallazzi F, Prossnitz ER, Sklar LA, Miao Y. Guo H, et al. Among authors: sklar la. Bioconjug Chem. 2009 Nov;20(11):2162-8. doi: 10.1021/bc9003475. Bioconjug Chem. 2009. PMID: 19817405 Free PMC article.

2

A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.

Guo H, Gallazzi F, Sklar LA, Miao Y. Guo H, et al. Among authors: sklar la. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5184-7. doi: 10.1016/j.bmcl.2011.07.055. Epub 2011 Jul 23. Bioorg Med Chem Lett. 2011. PMID: 21821417 Free PMC article.

3

Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.

Guo H, Shenoy N, Gershman BM, Yang J, Sklar LA, Miao Y. Guo H, et al. Among authors: sklar la. Nucl Med Biol. 2009 Apr;36(3):267-76. doi: 10.1016/j.nucmedbio.2009.01.003. Nucl Med Biol. 2009. PMID: 19324272 Free PMC article.

4

N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity.

Key TA, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER. Key TA, et al. Among authors: sklar la. J Biol Chem. 2003 Feb 7;278(6):4041-7. doi: 10.1074/jbc.M204687200. Epub 2002 Nov 6. J Biol Chem. 2003. PMID: 12424254 Free article.

5

Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.

Nayak TK, Hathaway HJ, Ramesh C, Arterburn JB, Dai D, Sklar LA, Norenberg JP, Prossnitz ER. Nayak TK, et al. Among authors: sklar la. J Nucl Med. 2008 Jun;49(6):978-86. doi: 10.2967/jnumed.107.048546. Epub 2008 May 15. J Nucl Med. 2008. PMID: 18483091 Free PMC article.

6

Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30.

Ramesh C, Nayak TK, Burai R, Dennis MK, Hathaway HJ, Sklar LA, Prossnitz ER, Arterburn JB. Ramesh C, et al. Among authors: sklar la. J Med Chem. 2010 Feb 11;53(3):1004-14. doi: 10.1021/jm9011802. J Med Chem. 2010. PMID: 20041667 Free PMC article.

7

Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.

Nayak TK, Dennis MK, Ramesh C, Burai R, Atcher RW, Sklar LA, Norenberg JP, Hathaway HJ, Arterburn JB, Prossnitz ER. Nayak TK, et al. Among authors: sklar la. ACS Chem Biol. 2010 Jul 16;5(7):681-90. doi: 10.1021/cb1000636. ACS Chem Biol. 2010. PMID: 20486699 Free PMC article.

8

Arrestin variants display differential binding characteristics for the phosphorylated N-formyl peptide receptor carboxyl terminus.

Potter RM, Key TA, Gurevich VV, Sklar LA, Prossnitz ER. Potter RM, et al. Among authors: sklar la. J Biol Chem. 2002 Mar 15;277(11):8970-8. doi: 10.1074/jbc.M111086200. Epub 2002 Jan 3. J Biol Chem. 2002. PMID: 11777932 Free article.

9

Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding.

Bennett TA, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER. Bennett TA, et al. Among authors: sklar la. J Biol Chem. 2001 Dec 28;276(52):49195-203. doi: 10.1074/jbc.M106414200. Epub 2001 Oct 15. J Biol Chem. 2001. PMID: 11602585 Free article.

10

Modulation of GPCR conformations by ligands, G-proteins, and arrestins.

Prossnitz ER, Sklar LA. Prossnitz ER, et al. Among authors: sklar la. Ernst Schering Found Symp Proc. 2006;(2):211-28. Ernst Schering Found Symp Proc. 2006. PMID: 17703584 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters